Previous Webinar – 14 April

“Most Favoured Nation” in the Nordics: Gaining clarity in an uncertain landscape

Most Favoured Nation (MFN) is a long-standing concept that has recently become highly topical. MFN now influences several strategic and tactical areas from pricing and launch strategies to market prioritisation. 

Yet it often remains misunderstood. And that’s no surprise: MFN is complex and rarely comes with straightforward answers. But the industry can still prepare and get the understanding required to make decisions in uncertain times. 

In this 30-minute webinar (14:00-14:30), Signum’s Senior Consultant, Line Kantsø, will provide you with:

• An introduction to MFN as a concept and its relevance to the Nordic pharmaceutical landscape. 
• A structured overview of the key processes and functions within pharma that may be affected across Denmark, Norway, and Sweden. 

Your take-aways from the webinar

You will leave with a clear framework for discussing MFN internally:

• Supporting internal alignment 
• Enabling more informed discussions around potential risks and interdependencies. 

Is this webinar for you?

MFN affects multiple functions across the pharmaceutical industry, both at headquarters and affiliate level. The webinar is therefore relevant for a wide range of roles. It may also be of interest to professionals outside of pharma who work with or are impacted by the MFN agenda.